By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ablexis 



San Francisco  California    U.S.A.
Phone: 415-978-2177 Fax: 415-978-1929


SEARCH JOBS


Industry
Biotechnology






Company News
Ablexis Announces Availability Of The AlivaMab Mouse Technology And Settlement Of The Litigation With Regeneron (REGN) 12/4/2014 2:01:25 PM
Ablexis Announces Availability Of The AlivaMab Mouse Technology And Settlement Of The Litigation With Regeneron (REGN) 12/4/2014 9:50:12 AM
Ablexis Announces Licensing of the AlivaMab Mouse Technology to Another Major Pharmaceutical Company 7/10/2012 10:21:51 AM
Ablexis Appoints Jake Bauer as Senior Director, Corporate Development and Business Operations 6/15/2011 6:35:37 AM
Ablexis Appoints Sean Stevens, Ph.D., as Vice President, Research 11/18/2010 12:22:09 PM
Ablexis Cuts Deal With Pfizer Inc. (PFE), Four Other Pharmas, For Antibody Drug Discovery Tool in Deal Worth up to $50 Million 10/26/2010 8:04:35 AM
Ablexis Maps Out New Antibody Drug Strategy with $12M From Third Rock Ventures, Pfizer Inc. (PFE) 6/23/2010 7:17:56 AM
Ablexis Appoints R. Scott Greer Chairman of the Board and Richard Hoffman Chief Business Officer 6/22/2010 6:55:35 AM
Ablexis Secures $12 Million in Series A Funding to Engineer and Commercialize Next-Generation Platforms for Antibody Drug Discovery 6/2/2010 6:33:31 AM
//-->